Author Manuscript Published OnlineFirst on January 21, 2016; DOI: 10.1158/0008-5472.CAN-15-1898 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Neural cell adhesion protein CNTN1 promotes the metastatic progression of prostate cancer Judy Yan,1 Diane Ojo,1 Anil Kapoor,2 Xiaozeng Lin,1 Jehonathan H. Pinthus,2 Tariq Aziz,3 Tarek A. Bismar,4 Fengxiang Wei,1,5 Nicholas Wong,1 Jason De Melo,1 Jean-Claude Cutz,3 Pierre Major,6 Geoffrey Wood,7 Hao Peng,8 and Damu Tang 1 * 1Division of Nephrology, Department of Medicine, 2Department of Surgery, 3Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada; 4Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada; 5The Genetics Laboratory, Institute of Women and Children’s Health, Longgang District, Shenzhen, China; 6Department of Oncology, McMaster University, Hamilton, Canada; 7Department of Veterinary Pathology, University of Guelph, Guelph, Canada; 8Department of Medical Physics & Applied Radiation Sciences, McMaster University, Hamilton, Canada Correspondence: Damu Tang 50 Charlton Ave East Hamilton Canada L8N 4A6 Tel: (905) 522-1155, x35168 Fax: (9050 540-6549; (905) 521-6181 Email:
[email protected] Running title: CNTN1 promotes prostate cancer progression Keywords: Contactin 1, prostate cancer, xenograft tumor, prostate cancer progression, and prostate cancer metastasis Conflicts of interest: A US provisional patent has been filed. J.Y., D.O., and D.T. hold the ownership 1 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 2016 American Association for Cancer Research. Author Manuscript Published OnlineFirst on January 21, 2016; DOI: 10.1158/0008-5472.CAN-15-1898 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.